Sign up to save your podcasts
Or
Share Episode 152: PRONOUNCE: Prostate Cancer Drugs and CVD
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 152: PRONOUNCE: Prostate Cancer Drugs and CVD
Renato Lopes and C. Michael Gibson discuss PRONOUNCE comparing the cardiovascular safety of degarelix vs. leuprolide in patients with advanced prostate cancer and CVD.
View all episodes
By TCTMD
4
22 ratings
Renato Lopes and C. Michael Gibson discuss PRONOUNCE comparing the cardiovascular safety of degarelix vs. leuprolide in patients with advanced prostate cancer and CVD.
More shows like Talking Points
View all
NEJM This Week
317 Listeners
JAMA Clinical Reviews
496 Listeners
JACC This Week
169 Listeners
This Week in Cardiology
883 Listeners
Heart Sounds Podcast
12 Listeners
The Curbsiders Internal Medicine Podcast
3,340 Listeners
Eagle's Eye View: Your Weekly CV Update From ACC.org
137 Listeners
Core IM | Internal Medicine Podcast
1,150 Listeners
Real Life Pharmacology - Pharmacology Education for Health Care Professionals
729 Listeners
Annals On Call Podcast
194 Listeners
JAMA Medical News
92 Listeners
The Clinical Problem Solvers
512 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
366 Listeners
Cardionerds: A Cardiology Podcast
429 Listeners
Critical Care Time
272 Listeners